Øyvind Midtvedt
- Senior consultant
Publications 2024
Characteristics and disease course of untreated patients with interstitial lung disease associated with systemic sclerosis in a real-life two-centre cohort
RMD Open, 10 (1)
DOI 10.1136/rmdopen-2023-003658, PubMed 38199606
Publications 2023
[A woman in her thirties with frequent mucosal ulcers]
Tidsskr Nor Laegeforen, 143 (8)
DOI 10.4045/tidsskr.22.0650, PubMed 37254975
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care Res (Hoboken), 76 (1), 88-97
DOI 10.1002/acr.25226, PubMed 37667424
Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
Rheumatology (Oxford), 62 (8), 2918-2929
DOI 10.1093/rheumatology/kead014, PubMed 36688692
Differential sensitivity of the 2020 revised comprehensive diagnostic criteria and the 2019 ACR/EULAR classification criteria across IgG4-related disease phenotypes: results from a Norwegian cohort
Arthritis Res Ther, 25 (1), 163
DOI 10.1186/s13075-023-03155-y, PubMed 37670401
Publications 2022
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
Front Immunol, 13, 991743
DOI 10.3389/fimmu.2022.991743, PubMed 36211384
A man in his sixties with chondritis and bone marrow failure
Tidsskr Nor Laegeforen, 142 (4)
DOI 10.4045/tidsskr.21.0370, PubMed 35239266
Serum markers of cardiac complications in a systemic sclerosis cohort
Sci Rep, 12 (1), 4661
DOI 10.1038/s41598-022-08815-8, PubMed 35304587
Gastrointestinal symptom severity and progression in systemic sclerosis
Rheumatology (Oxford), 61 (10), 4024-4034
DOI 10.1093/rheumatology/keac118, PubMed 35238377
Publications 2021
Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol, 73 (7), 1277-1287
DOI 10.1002/art.41665, PubMed 33497027
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trial
BMJ Open, 11 (6), e048541
DOI 10.1136/bmjopen-2020-048541, PubMed 34168032
Publications 2020
Fecal microbiota transplantation in systemic sclerosis: A double-blind, placebo-controlled randomized pilot trial
PLoS One, 15 (5), e0232739
DOI 10.1371/journal.pone.0232739, PubMed 32437393
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort
Rheumatology (Oxford), 59 (10), 2920-2929
DOI 10.1093/rheumatology/keaa026, PubMed 32097470
Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis
Eur Med J (Chelmsf), 7, 110-118
DOI 10.33590/emj/20-00043, PubMed 36711108
Publications 2019
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
Rheumatology (Oxford), 58 (2), 313-320
DOI 10.1093/rheumatology/key285, PubMed 30281089
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Am J Respir Crit Care Med, 200 (10), 1258-1266
DOI 10.1164/rccm.201903-0486OC, PubMed 31310156
Systolic Dysfunction in Systemic Sclerosis: Prevalence and Prognostic Implications
ACR Open Rheumatol, 1 (4), 258-266
DOI 10.1002/acr2.1037, PubMed 31777802
Publications 2018
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
Ann Rheum Dis, 77 (4), 563-570
DOI 10.1136/annrheumdis-2017-211912, PubMed 29306872
Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort
Rheumatology (Oxford), 57 (3), 480-487
DOI 10.1093/rheumatology/kex435, PubMed 29237073
CCL21 as a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis
Arthritis Rheumatol, 70 (10), 1644-1653
DOI 10.1002/art.40534, PubMed 29687634
Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis
PLoS One, 13 (11), e0206545
DOI 10.1371/journal.pone.0206545, PubMed 30457999
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
Rheumatology (Oxford), 57 (2), 370-381
DOI 10.1093/rheumatology/kex410, PubMed 29207002
Publications 2017
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS)
Ann Rheum Dis, 76 (7), 1207-1218
DOI 10.1136/annrheumdis-2016-210503, PubMed 28188239
Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort
J Rheumatol, 44 (4), 459-465
DOI 10.3899/jrheum.160867, PubMed 28089974
Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts
BMJ Open Gastroenterol, 4 (1), e000134
DOI 10.1136/bmjgast-2017-000134, PubMed 28761687
Publications 2016
High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis
Chest, 150 (2), 299-306
DOI 10.1016/j.chest.2016.03.004, PubMed 26997242
Publications 2015
Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis
Arthritis Rheumatol, 67 (8), 2205-12
DOI 10.1002/art.39166, PubMed 25916462
Publications 2014
Dysfunctional arteriovenous anastomoses in hands of systemic sclerosis patients with digital ulcers
Clin Exp Rheumatol, 32 (6 Suppl 86), S-53-9
PubMed 24847906
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease
J Rheumatol, 42 (1), 60-3
DOI 10.3899/jrheum.140047, PubMed 25274890
Overnight response to infliximab in neurosarcoidosis: a case report and review of infliximab treatment practice
Clin Neuropharmacol, 37 (5), 142-8
DOI 10.1097/WNF.0000000000000047, PubMed 25229171
[A man in his forties with swelling in both orbits]
Tidsskr Nor Laegeforen, 134 (15), 1472-6
DOI 10.4045/tidsskr.13.0115, PubMed 25138406
[Ø. Midtvedt and colleagues reply]
Tidsskr Nor Laegeforen, 134 (19), 1823
DOI 10.4045/tidsskr.14.1151, PubMed 25314975
[Woman with recurrent uveitis and neurological symptoms]
Tidsskr Nor Laegeforen, 134 (12-13), 1245-8
DOI 10.4045/tidsskr.13.0433, PubMed 24989204
Publications 2013
Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis
J Rheumatol, 40 (7), 1127-33
DOI 10.3899/jrheum.121390, PubMed 23637316
Publications 2012
Prevalence of systemic sclerosis in south-east Norway
Rheumatology (Oxford), 51 (9), 1600-5
DOI 10.1093/rheumatology/kes076, PubMed 22539477
Publications 2011
[A woman with recurrent urticaria, joint pain and fever]
Tidsskr Nor Laegeforen, 131 (2), 135-6
DOI 10.4045/tidsskr.10.0354, PubMed 21267032
Publications 2010
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database
J Rheumatol, 37 (7), 1488-501
DOI 10.3899/jrheum.091165, PubMed 20551097
Treatment of Schnitzler's syndrome with anakinra: report of three cases and review of the literature
Scand J Rheumatol, 40 (1), 74-9
DOI 10.3109/03009742.2010.493894, PubMed 20936987
Publications 2006
[Ischemic ulcers in systemic connective tissue disorders]
Tidsskr Nor Laegeforen, 126 (23), 3089-92
PubMed 17160111
Publications 2005
[Pathophysiologic aspects of systemic sclerosis]
Tidsskr Nor Laegeforen, 125 (19), 2622-3
PubMed 16215604